METHICILLIN-RESISTANT STAPHYLOCOCCAL INFECTIONS IN AN OUTPATIENT PERITONEAL-DIALYSIS PROGRAM

被引:21
作者
HOLLEY, JL [1 ]
BERNARDINI, J [1 ]
JOHNSTON, JR [1 ]
PIRAINO, B [1 ]
机构
[1] VET ADM MED CTR,PITTSBURGH,PA
关键词
methicillin resistance; peritoneal dialysis; peritonitis; Staphylococcal infections;
D O I
10.1016/S0272-6386(12)80569-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In view of the increasing concern about hospital-acquired methicillin resistance, we examined the sensitivities and outcome of staphylococcal infections related to outpatient peritoneal dialysis over a 5-year period. Data on all episodes of peritonitis (n = 360) and catheter infections (n = 507) were gathered prospectively from January 1984 to December 1988. The numbers of patients on peritoneal dialysis each year ranged from 136 in 1984 to 109 in 1987. Fifteen methicillin-resistant staphylococcal infections (MRSI) related to outpatient peritoneal dialysis occurred. Three were due to methicillin-resistant Staphylococcu S aureus found in infected exit sites (2.3% of all S aureus catheter infections). Two of these infections occurred in a continuous ambulatory peritoneal dialysis (CAPD) patient who carried methicillin-resistant S aureus in his nares. The other 12 methicillin-resistant organisms were coagulase-negative staphylococci that caused peritonitis. There was a significant increase in the percentage of episodes of coagulase-negative staphylococci peritonitis caused by methicillin-resistant organisms; from 5% (3157) in 1984 through 1986 to 28% (9132) in 1987 through 1988 (P<0.005). In view of the high percentage of coagulase-negative staphylococci peritonitis that is methicillin-resistant, vancomycin rather than cephalosporins should be used for initial treatment. © 1990, National Kidney Foundation Inc.. All rights reserved.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 31 条
[1]  
ABRAHAM G, 1984, KIDNEY INT, V25, P539
[2]  
Acar J F, 1970, Antimicrob Agents Chemother (Bethesda), V10, P280
[4]  
BINT AJ, 1987, LANCET, V1, P845
[5]   INTRAPERITONEAL (IP) VANCOMYCIN THERAPY FOR CAPD PERITONITIS - A PROSPECTIVE, RANDOMIZED COMPARISON OF INTERMITTENT NU CONTINUOUS THERAPY [J].
BOYCE, NW ;
WOOD, C ;
THOMSON, NM ;
KERR, P ;
ATKINS, RC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (04) :304-306
[6]   VANCOMYCIN AND NETILMICIN AS 1ST LINE TREATMENT OF PERITONITIS IN CAPD PATIENTS [J].
BRAUNER, L ;
KAHLMETER, G ;
LINDHOLM, T ;
SIMONSEN, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (06) :751-758
[7]   METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
BRUMFITT, W ;
HAMILTONMILLER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1188-1196
[8]   CHARACTERIZATION OF CLINICALLY SIGNIFICANT STRAINS OF COAGULASE-NEGATIVE STAPHYLOCOCCI [J].
CHRISTENSEN, GD ;
PARISI, JT ;
BISNO, AL ;
SIMPSON, WA ;
BEACHEY, EH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (02) :258-269
[9]  
DAVIES SJ, 1989, PERITON DIALYSIS INT, V9, P61
[10]  
EISENBERG ES, 1987, NEW ENGL J MED, V317, P767